Koios is pleased to announce that its KOIOS™ nootropic functional beverages have been approved for placement in over 600 CVS locations. CVS is the largest retail pharmacy chain in the United States and one of the largest corporations in the world.
DENVER and VANCOUVER, British Columbia, May 09, 2022 (GLOBE NEWSWIRE) -- Koios Beverage Corp. (CSE: FIT; OTC: FITSF) (the "Company" or "Koios") is pleased to announce that its KOIOS™ nootropic functional beverages have been approved for placement and are now available in over 600 CVS locations in Texas, Tennessee, Missouri, New Jersey, California, Florida, Indiana and New York.
CVS Pharmacy is a subsidiary of CVS Health Corp. (NYSE: CVS), the 4th largest U.S. corporation by FY2021 revenues in the Fortune 5001. In 2021, it reported $292.1 billion in revenue2.
CVS has over 9000 retail locations, approximately 256,000 employees, and serves 4.5 million retail pharmacy customers daily3. It is the largest pharmacy chain in the United States by number of locations and prescription revenue.
"We are thrilled to be working with the largest retail pharmacy in the country," said Koios CEO and founder Chris Miller. "CVS is leading the charge in health solutions for the world, and we’re excited for our brand’s functional and healthy beverages to be a part of that. Our mission is to make the world a healthier place and our partnership with CVS will help us succeed in this.”
To date in 2022, Koios has announced that its functional beverages have been approved for placement at United Supermarkets, a subsidiary of Albertsons, Ingles Markets, Tony’s Fresh Market, Raley’s, and Harris Teeter. The Company’s effort to place its KOIOS™ and Fit Soda™ beverages in regional and national grocery chains is part of a strategy to gain new placements in more national chains.
Miller continues, “Partnering with CVS is part of our strategy to continue placing our products in the biggest retailers in the world to expand our market footprint. Growth for Koios is high right now and we expect to continue seeing growth at a rapid pace as we gain momentum across the marketplace.”
With approval for KOIOS™ beverages to be sold in CVS, new placements could be more rapidly finalized and enable the Company to further grow its base of more than 6,000 retail locations in the United States.